Results 181 to 190 of about 180,784 (340)

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Hepatic stellate cells promote structural and functional remodeling of three-dimensional hepatocellular carcinoma coculture spheroids. [PDF]

Mol Biol Rep
Obelar J, Vasconcellos JG, do Nascimento NB, de Sousa AC, Giehl M, Simões Fischer B, de Souza Ferreira J, de Oliveira J, Trindade VMT, Guma FTCR.   +9 more
europepmc   +1 more source

s-ccs/ClusterDepth.jl: v0.2.1

<h2>ClusterDepth v0.2.1</h2> <p><a href="https://github.com/s-ccs/ClusterDepth.jl/compare/v0.2.0...v0.2.1">Diff since v0.2.0</a></p> <ul> <li>update Docs for UnfoldSim</li> <li>formatted ...
Benedikt Ehinger, Maanik Marathe
core   +1 more source

Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer

Molecular Oncology, EarlyView.
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu, Puspa Das, Xing Zhang, Xiaodong Cheng   +3 more
wiley   +1 more source

Turkish version of the Carolinas comfort scale: Validation and long-term clinical outcomes after mesh-based inguinal hernia repair. [PDF]

Turk J Surg
Bulut A, Ekdal DC, Acar ÖF, Ekşim B, El Qadiri IM, Semiz M, Mankan N, Günal Ö.   +7 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Mechanism of injury and fracture status influence outcomes after central cord injury. [PDF]

iScience
Pedro KM, Alvi MA, Zang K, Lozano C, Badhiwala JH, Wilson JR, Harrop JS, Guest JD, Aarabi B, Shaffrey CI, Fehlings MG.   +10 more
europepmc   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

Clustering and Source Association of Clinical and Nonclinical Listeria monocytogenes Isolates, New York, USA, 2000-2021¹. [PDF]

Emerg Infect Dis
Samut H, Mendez-Vallellanes DV, Hoyt H, Wirth SE, Mingle L, Sauders BD, Deiulio GA, Dickey AW, Ishida ML, Wolfgang WJ, Musser KA, Wiedmann M, Orsi RH.   +12 more
europepmc   +1 more source

Partial FAK suppression promotes tumor growth, an effect reversed by macrophage p110δ PI3K inactivation

Molecular Oncology, EarlyView.
Partial inhibition of focal adhesion kinase (FAK) can paradoxically promote tumor growth, rather than simply producing a weaker antitumor effect than that observed with strong FAK suppression. In breast cancer and melanoma models, targeting p110δ PI3K, particularly in macrophages, counteracted these tumor‐promoting effects, highlighting the importance ...
Lydia Xenou, Niki Tzenaki, Anna Tsapara, Maria Tzardi, Evangelia A. Papakonstanti   +4 more
wiley   +1 more source